Moderna Inc
USUSDModerna Inc (LSE:0A45) — Biotechnology: Biological Products (No Diagnostic Substances). Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 3. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
Über das Unternehmen
- Website
- modernatx.com
- Investor Relations
- investors.modernatx.com/
- Sektor
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Hauptsitz
- Cambridge, United States
- Management
- Stéphane Bancel
- Mitarbeiter
- 5 800
- Gegründet
- 2010
- Ausstehende Aktien
- 399.24 Mio. Stand 2026-07-24
- Streubesitz
- 372.19 Mio.
- Marktkapitalisierung
- 76.88 Mrd. USD
- Insider
- 7.34%
- Institutionelle Anleger
- 80.46%
- Branche (SIC)
- Biological Products, (No Diagnostic Substances)
- Rechtsform
- XTIQ
- ISIN
- US60770K1079
- LEI
- 549300EI6OKH5K5Q2G38
- P/E
- 5.8
- P/B
- 11.8
- FCF
- −1.24 Mrd. USD
- Schulden
- 591 Mio. USDNettoliquidität
- Gewinne und FCF – für die 12 Monate bis 30.06.2026 (aktueller Bericht des Unternehmens).
- NAV
Beschreibung
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| FMR, LLC | 12.99% | 51.86 Mio. | 2026-06-30 |
| Blackrock Inc. | 7.66% | 30.6 Mio. | 2026-06-30 |
| Vanguard Capital Managem… | 5.81% | 23.21 Mio. | 2026-06-30 |
| Capital World Investors | 5.58% | 22.28 Mio. | 2026-06-30 |
| Stéphane Bancel (Chief E… | ≈5.56% | 22.22 Mio. | 2026-08-06 |
| BAILLIE GIFFORD & CO | 4.56% | 18.21 Mio. | 2026-06-30 |
| State Street Corporation | 3.94% | 15.73 Mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 3.9% | 15.58 Mio. | 2026-06-30 |
| Growth Fund of America | 3.75% | 14.98 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.84% | 11.33 Mio. | 2026-06-30 |
| Geode Capital Management… | 2.43% | 9.71 Mio. | 2026-06-30 |
| Morgan Stanley | 2.39% | 9.54 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 9.15 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.05% | 8.19 Mio. | 2026-06-30 |
| Theleme Partners LLP | 2.02% | 8.06 Mio. | 2026-06-30 |
| Fidelity Mt. Vernon Stre… | 1.7% | 6.79 Mio. | 2026-07-31 |
| Fidelity Securities Fund… | 1.33% | 5.31 Mio. | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 1.3% | 5.19 Mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.18% | 4.7 Mio. | 2026-08-31 |
| AMERICAN FUNDS INSURANCE… | 1.16% | 4.62 Mio. | 2026-06-30 |
| VANGUARD WORLD FUND-Vang… | 1.15% | 4.58 Mio. | 2026-05-31 |
| HOGE STEPHEN (President) | ≈0.43% | 1.72 Mio. | 2026-09-15 |
| KLINGER SHANNON THYME (O… | ≈0.02% | 81 340 | 2026-09-04 |
| MOCK JAMES M (Chief Fina… | ≈0.01% | 59 375 | 2026-09-10 |
| NADER FRANCOIS E. (Direc… | ≈0.01% | 32 781 | 2026-04-30 |
| NABEL ELIZABETH G (Direc… | ≈0% | 19 317 | 2026-04-30 |
| HORNING SANDRA (Director… | ≈0% | 18 585 | 2026-04-30 |
| HUSSAIN SHAH ABBAS (Dire… | ≈0% | 12 066 | 2026-05-01 |
| Robert S. Langer, Jr. | — | — | — |
| Noubar Afeyan (Director) | — | — | 2026-05-21 |
| SAGAN PAUL L (Director) | — | — | 2025-03-03 |
Mit Google Anmelden